Investing in healthcare isn’t for the fainthearted – the strategy is prone to cyclical criticism, particularly in the US, over whether private equity is an appropriate owner for assets in primary healthcare such as medical practices.
For those who can stomach the headwinds, the sector can prove appealing. Healthcare assets can benefit from recession-resistant demand, have favourable demographic tailwinds such as an ageing global population and are often in areas that can benefit from the implementation of technological and therapeutic innovations, as Private Equity International reported over the summer.
